Literature DB >> 19889928

Small intestine CD4+ cell reduction and enteropathy in simian/human immunodeficiency virus KS661-infected rhesus macaques in the presence of low viral load.

Katsuhisa Inaba1, Yoshinori Fukazawa, Kenta Matsuda, Ai Himeno, Megumi Matsuyama, Kentaro Ibuki, Yoshiharu Miura, Yoshio Koyanagi, Atsushi Nakajima, Richard S Blumberg, Hidemi Takahashi, Masanori Hayami, Tatsuhiko Igarashi, Tomoyuki Miura.   

Abstract

Human immunodeficiency virus type 1, simian immunodeficiency virus and simian/human immunodeficiency virus (SHIV) infection generally lead to death of the host accompanied by high viraemia and profound CD4(+) T-cell depletion. SHIV clone KS661-infected rhesus macaques with a high viral load set point (HVL) ultimately experience diarrhoea and wasting at 6-12 months after infection. In contrast, infected macaques with a low viral load set point (LVL) usually live asymptomatically throughout the observation period, and are therefore referred to as asymptomatic LVL (Asym LVL) macaques. Interestingly, some LVL macaques exhibit diarrhoea and wasting similar to the symptoms of HVL macaques and are termed symptomatic LVL (Sym LVL) macaques. This study tested the hypothesis that Sym LVL macaques have the same degree of intestinal abnormalities as HVL macaques. The proviral DNA loads in lymphoid tissue and the intestines of Sym LVL and Asym LVL macaques were comparable and all infected monkeys showed villous atrophy. Notably, the CD4(+) cell frequencies of lymphoid tissues and intestines in Sym LVL macaques were remarkably lower than those in Asym LVL and uninfected macaques. Furthermore, Sym LVL and HVL macaques exhibited an increased number of activated macrophages. In conclusion, intestinal disorders including CD4(+) cell reduction and abnormal immune activation can be observed in SHIV-KS661-infected macaques independent of virus replication levels.

Entities:  

Mesh:

Year:  2009        PMID: 19889928      PMCID: PMC3192539          DOI: 10.1099/vir.0.017368-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  33 in total

1.  Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection.

Authors:  R S Veazey; K G Mansfield; I C Tham; A C Carville; D E Shvetz; A E Forand; A A Lackner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo.

Authors:  R S Veazey; I C Tham; K G Mansfield; M DeMaria; A E Forand; D E Shvetz; L V Chalifoux; P K Sehgal; A A Lackner
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Local macrophage proliferation correlates with increased renal M-CSF expression in human glomerulonephritis.

Authors:  N M Isbel; D J Nikolic-Paterson; P A Hill; J Dowling; R C Atkins
Journal:  Nephrol Dial Transplant       Date:  2001-08       Impact factor: 5.992

4.  Jejunal enteropathy associated with human immunodeficiency virus infection: quantitative histology.

Authors:  P A Batman; A R Miller; S M Forster; J R Harris; A J Pinching; G E Griffin
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

5.  CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.

Authors:  Gilbert R Kaufmann; Luc Perrin; Guiseppe Pantaleo; Milos Opravil; Hansjakob Furrer; Amalio Telenti; Bernard Hirschel; Bruno Ledergerber; Pietro Vernazza; Enos Bernasconi; Martin Rickenbach; Matthias Egger; Manuel Battegay
Journal:  Arch Intern Med       Date:  2003-10-13

6.  Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy.

Authors:  Giulia Marchetti; Giusi M Bellistrì; Elisa Borghi; Camilla Tincati; Stefania Ferramosca; Maria La Francesca; Giulia Morace; Andrea Gori; Antonella D'Arminio Monforte
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

7.  Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

Authors:  Mette D Hazenberg; Sigrid A Otto; Birgit H B van Benthem; Marijke Th L Roos; Roel A Coutinho; Joep M A Lange; Dörte Hamann; Maria Prins; Frank Miedema
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

Review 8.  Macrophage HIV-1 infection and the gastrointestinal tract reservoir.

Authors:  Phillip D Smith; Gang Meng; Jesus F Salazar-Gonzalez; George M Shaw
Journal:  J Leukoc Biol       Date:  2003-08-11       Impact factor: 4.962

9.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

10.  CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.

Authors:  Kevin J Maloy; Laurence Salaun; Rachel Cahill; Gordon Dougan; Nigel J Saunders; Fiona Powrie
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

View more
  1 in total

1.  Quantification system for the viral dynamics of a highly pathogenic simian/human immunodeficiency virus based on an in vitro experiment and a mathematical model.

Authors:  Shingo Iwami; Benjamin P Holder; Catherine A A Beauchemin; Satoru Morita; Tetsuko Tada; Kei Sato; Tatsuhiko Igarashi; Tomoyuki Miura
Journal:  Retrovirology       Date:  2012-02-25       Impact factor: 4.602

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.